SOME PARAMETERS AFFECTING EFFICACY OF ANTI INTERLEUKIN-2 RECEPTOR MONOCLONAL ANTIBODY (IL-2R mAb) THERAPY IN RAT RECIPIENTS OF CARDIAC ALLOGRAFTS